39 / 100
1. The relevant market is
defined to be outpatient
haemodialysis treatment
in dialysis centres
operatedbyrestructured
hospitals and private
sector service providers,
including joint ventures
between restructured
hospitals and private
operators in Singapore.
Accordingly, the relevant
marketexcludesservices
provided by Voluntary
Welfare Organisations.
2. Market shares are based
on estimated number of
patients.
3. For the regional analysis
of the kidney dialysis
market, the market is
divided into smaller
regions namely, North,
Central, East, West and
Northeast.
4. Advance Renal Care,
Kidneycare, Pacific
Advance Renal Care,
and ARCA (Farrer Park)
Dialysis entered the
kidney dialysis market
after the merger.
Based on the study, CCS found that, in the period of December 2012 to June 2015:
The Paper has been independently reviewed by Assistant Professor Aamir Hashmi,
National University of Singapore. He concluded that the Paper provided convincing
evidence that CCS’s decision on the merger did not cause any adverse effect on
competition in the kidney dialysis market.
CAPACITY OF DIALYSIS SERVICES IN SINGAPORE INCREASED
, THE NUMBER OF
DIALYSIS CENTRES INCREASED FROM 39 TO 60, AND THE CAPACITY OFTREATMENT
SLOTS INCREASED FROMABOUT 2,000 TO ALMOST 3,000 PERWEEK.
FMC’S MARKET SHARE FELL FROM 70% TO 53% DUE TO THE EXPANSION AND
ENTRY OF COMPETING FIRMS.
[2]
NEW DIALYSIS CENTRES WERE SET UP BY COMPETING PROVIDERS ACROSS
ALL FIVE MAJOR SUB-REGIONS OF SINGAPORE
[3]
, AND THESE CENTRES WERE
ABLE TO ACHIEVE SIMILAR USAGE RATES TO THOSE OF FMC.
[4]
THIS FINDING IS
CONSISTENT WITH CCS’S EARLIER ASSESSMENT THAT BARRIERS TO ENTRY AND
EXPANSION IN THE MARKET WERE NOT HIGH.
PRICES FOR DIALYSIS FELL
RELATIVE TO PRICES FOR OTHER MEDICAL
TREATMENTS. THE STUDY ALSO SHOWED THAT AVERAGE PRICES FOR DIALYSIS
DID NOT INCREASE.
1
2
3
Source: The Straits Times (26 April 2016) ©
SingaporePressHoldingsLimited.Permission
required for reproduction
37
CCS ANNUAL REPORT 2015-2016
GUIDING YOU TO NEW HEIGHTS